Patients
Physicians
The Science
Show submenu for The Science
ACP-01 Stem Cell Therapy
Clinical Research
Publications
Show submenu for Publications
Scientific Publications
News
Events
Resources
Show submenu for Resources
Peripheral Arterial Disease PAD
Chronic Limb Threatening Ischemia CLTI
Cardiovascular Ischemia/Angina
Vascular Dementia
Wound Care
Our Blog
About
Patients
Physicians
The Science
Show submenu for The Science
ACP-01 Stem Cell Therapy
Clinical Research
Publications
Show submenu for Publications
Scientific Publications
News
Events
Resources
Show submenu for Resources
Peripheral Arterial Disease PAD
Chronic Limb Threatening Ischemia CLTI
Cardiovascular Ischemia/Angina
Vascular Dementia
Wound Care
Our Blog
About
Topic
Investor Relations
investor-relations
All Post
Investor Relations
Latest News
Chronic Limb Threatening Ischemia
Uncategorized
Angina
Stem Cells
Vascular Dementia
Wound Care
Search
HEMOSTEMIX CLOSES $303,967 PRIVATE PLACEMENT AT $0.12 PER SHARE
Read More
Hemostemix’s Insider Lead Order of $330,000 Private Placement
Read More
HEMOSTEMIX CLOSES $480,000 PRIVATE PLACEMENT AT $0.12 PER SHARE
Read More
Hemostemix Inc. Announces FDA Pre-IND Meeting and NBPP of $960,000
Read More
Hemostemix Grants Stock Options
Read More
Hemostemix to Attend DFU 2025 San Antonio and Closed its Private Placement
Read More
Hemostemix Starts its Roll-up of Cardiology Practices, Acquiring Two
Read More
Investor Relations
Hemostemix Closes CDN $280,594 Private Placement
Read More
Hemostemix Presents ACP-01 Data at University of Florida Grand Rounds
Read More
Hemostemix Closes Private Placement of $461,230
Read More
1
2
3
4
5